Bet on health with ‘Obesity ETF’ and other index funds
Janus Capital Group this week filed a preliminary prospectus with the SEC for four new, health-related ETFs, covering obesity, health and fitness, long-term care and organic products.
Janus Capital Group this week filed a preliminary prospectus with the SEC for four new, health-related ETFs, covering obesity, health and fitness, long-term care and organic products.
CRISPR gene editing technology is one of the most intriguing growth fields in biotech, says Deerfield Management president Jim Flynn. The venture firm just launched a new $550 million fund, and it'll focus on seeding startups and funding new companies - and is very interested in this space.